Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Rapid alterations to marine microbiota communities following an oil spill.

Gemmell BJ, Bacosa HP, Dickey BO, Gemmell CG, Alqasemi LR, Buskey EJ.

Ecotoxicology. 2018 Jul;27(5):505-516. doi: 10.1007/s10646-018-1923-7. Epub 2018 Mar 19.

PMID:
29556940
2.

In Vitro Activity of Iclaprim against Methicillin-Resistant Staphylococcus aureus Nonsusceptible to Daptomycin, Linezolid, or Vancomycin: A Pilot Study.

Huang DB, Hawser S, Gemmell CG, Sahm DF.

Can J Infect Dis Med Microbiol. 2017;2017:3948626. doi: 10.1155/2017/3948626. Epub 2017 Dec 17.

3.

Telavancin shows superior activity to vancomycin with multidrug-resistant Staphylococcus aureus in a range of in vitro biofilm models.

Smith K, Gemmell CG, Lang S.

Eur J Clin Microbiol Infect Dis. 2013 Oct;32(10):1327-32. doi: 10.1007/s10096-013-1883-z. Epub 2013 Apr 29.

PMID:
23624635
4.

Minor groove binders as anti-infective agents.

Barrett MP, Gemmell CG, Suckling CJ.

Pharmacol Ther. 2013 Jul;139(1):12-23. doi: 10.1016/j.pharmthera.2013.03.002. Epub 2013 Mar 16. Review.

PMID:
23507040
5.

In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.

Desbois AP, Gemmell CG, Coote PJ.

Int J Antimicrob Agents. 2010 Jun;35(6):559-65. doi: 10.1016/j.ijantimicag.2010.01.016. Epub 2010 Mar 4.

PMID:
20206480
6.

Influence of tigecycline on expression of virulence factors in biofilm-associated cells of methicillin-resistant Staphylococcus aureus.

Smith K, Gould KA, Ramage G, Gemmell CG, Hinds J, Lang S.

Antimicrob Agents Chemother. 2010 Jan;54(1):380-7. doi: 10.1128/AAC.00155-09. Epub 2009 Oct 26.

7.

Surface disinfection properties of the combination of an antimicrobial peptide, ranalexin, with an endopeptidase, lysostaphin, against methicillin-resistant Staphylococcus aureus (MRSA).

Desbois AP, Lang S, Gemmell CG, Coote PJ.

J Appl Microbiol. 2010 Feb;108(2):723-30. doi: 10.1111/j.1365-2672.2009.04472.x. Epub 2009 Jul 13.

8.

Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin.

Smith K, Perez A, Ramage G, Gemmell CG, Lang S.

Int J Antimicrob Agents. 2009 Apr;33(4):374-8. doi: 10.1016/j.ijantimicag.2008.08.029. Epub 2008 Dec 19.

PMID:
19101124
9.

Usefulness of mec-associated direct repeat unit (dru) typing in the epidemiological analysis of highly clonal methicillin-resistant Staphylococcus aureus in Scotland.

Goering RV, Morrison D, Al-Doori Z, Edwards GF, Gemmell CG.

Clin Microbiol Infect. 2008 Oct;14(10):964-9. doi: 10.1111/j.1469-0691.2008.02073.x.

10.

Biofilm formation by Scottish clinical isolates of Staphylococcus aureus.

Smith K, Perez A, Ramage G, Lappin D, Gemmell CG, Lang S.

J Med Microbiol. 2008 Aug;57(Pt 8):1018-23. doi: 10.1099/jmm.0.2008/000968-0.

PMID:
18628505
11.

The association between biocide tolerance and the presence or absence of qac genes among hospital-acquired and community-acquired MRSA isolates.

Smith K, Gemmell CG, Hunter IS.

J Antimicrob Chemother. 2008 Jan;61(1):78-84. Epub 2007 Nov 2.

PMID:
17981834
12.

Antimicrobial lexitropsins containing amide, amidine, and alkene linking groups.

Anthony NG, Breen D, Clarke J, Donoghue G, Drummond AJ, Ellis EM, Gemmell CG, Helesbeux JJ, Hunter IS, Khalaf AI, Mackay SP, Parkinson JA, Suckling CJ, Waigh RD.

J Med Chem. 2007 Nov 29;50(24):6116-25. Epub 2007 Oct 26.

PMID:
17960927
13.

Relationship between mucosal levels of interleukin 8 and toxinogenicity of Helicobacter pylori.

Zhang QB, Etolhi G, Dawodu JB, Husain A, Gemmell CG, Russell RI.

Inflammopharmacology. 1998;6(2):109-17.

PMID:
17694368
14.

Low-level exposure of MRSA to octenidine dihydrochloride does not select for resistance.

Al-Doori Z, Goroncy-Bermes P, Gemmell CG, Morrison D.

J Antimicrob Chemother. 2007 Jun;59(6):1280-1. Epub 2007 Apr 17. No abstract available.

PMID:
17439976
15.

Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.

Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, Warren RE; Joint Working Party of the British Society for Joint Working Party of the British Society for Antimicrobial Chemotherapy, Hospital Infection Society and Infection Control Nurses Association.

J Antimicrob Chemother. 2006 Apr;57(4):589-608. Epub 2006 Feb 28. Review.

PMID:
16507559
16.

Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents.

Smith AJ, Hall V, Thakker B, Gemmell CG.

J Antimicrob Chemother. 2005 Aug;56(2):407-9. Epub 2005 Jun 21.

PMID:
15972310
17.

Glycopeptide resistance in Staphylococcus aureus: is it a real threat?

Gemmell CG.

J Infect Chemother. 2004 Apr;10(2):69-75. Review.

PMID:
15160298
19.

Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus.

Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, Gemmell CG, Kim MN, Ploy MC, El-Solh N, Ferraz V, Hiramatsu K.

J Clin Microbiol. 2003 Jan;41(1):5-14.

20.

Gingivitis and toothbrushes: potential roles in viridans streptococcal bacteraemia.

Kennedy HF, Morrison D, Tomlinson D, Gibson BE, Bagg J, Gemmell CG.

J Infect. 2003 Jan;46(1):67-70.

PMID:
12504614
21.

Virulence factor expression by Gram-positive cocci exposed to subinhibitory concentrations of linezolid.

Gemmell CG, Ford CW.

J Antimicrob Chemother. 2002 Nov;50(5):665-72.

PMID:
12407122
22.

Bacteriostatic activity of human lactoferrin against Staphylococcus aureus is a function of its iron-binding properties and is not influenced by antibiotic resistance.

Aguila A, Herrera AG, Morrison D, Cosgrove B, Perojo A, Montesinos I, Pérez J, Sierra G, Gemmell CG, Brock JH.

FEMS Immunol Med Microbiol. 2001 Aug;31(2):145-52.

23.

Putative virulence factor expression by clinical and food isolates of Bacillus spp. after growth in reconstituted infant milk formulae.

Rowan NJ, Deans K, Anderson JG, Gemmell CG, Hunter IS, Chaithong T.

Appl Environ Microbiol. 2001 Sep;67(9):3873-81.

24.
25.
26.

Emerging concepts in the management of the malignant haematological disorders.

Jønsson V, Gemmell CG, Wiik A.

Expert Opin Pharmacother. 2000 May;1(4):713-35. Review.

PMID:
11249512
27.

Origins of Staphylococcus epidermidis and Streptococcus oralis causing bacteraemia in a bone marrow transplant patient.

Kennedy HF, Morrison D, Kaufmann ME, Jackson MS, Bagg J, Gibson BE, Gemmell CG, Michie JR.

J Med Microbiol. 2000 Apr;49(4):367-70.

PMID:
10755632
28.

Where is typing going?

Gemmell CG.

J Hosp Infect. 1999 Dec;43 Suppl:S89-92.

PMID:
10658763
29.

Relationship between mucosal levels of Helicobacter pylori-specific IgA, interleukin-8 and gastric inflammation.

Zhang QB, Etolhi G, Dawodu JB, Gemmell CG, Russell RI.

Clin Sci (Lond). 1999 Apr;96(4):409-14.

PMID:
10087249
30.

Attenuated neutrophil respiratory burst following acute hypoglycaemia in diabetic patients and normal subjects.

Thomson GA, Fisher BM, Gemmell CG, MacCuish AC, Gallacher SJ.

Acta Diabetol. 1997 Dec;34(4):253-6.

PMID:
9451468
31.

Role of certain virulence factors in a murine model of Staphylococcus aureus arthritis.

Gemmell CG, Goutcher SC, Reid R, Sturrock RD.

J Med Microbiol. 1997 Mar;46(3):208-13.

PMID:
9126821
32.

Relationship between the mucosal production of reactive oxygen radicals and density of Helicobacter pylori in patients with duodenal ulcer.

Zhang Q, Dawodu JB, Etolhi G, Husain A, Gemmell CG, Russell RI.

Eur J Gastroenterol Hepatol. 1997 Mar;9(3):261-5.

PMID:
9096427
33.

Persistence of Staphylococcus aureus as detected by polymerase chain reaction in the synovial fluid of a patient with septic arthritis.

Canvin JM, Goutcher SC, Hagig M, Gemmell CG, Sturrock RD.

Br J Rheumatol. 1997 Feb;36(2):203-6.

PMID:
9133930
34.

Association of antral mucosal levels of interleukin 8 and reactive oxygen radicals in patients infected with Helicobacter pylori.

Zhang QB, Dawodu JB, Husain A, Etolhi G, Gemmell CG, Russell RI.

Clin Sci (Lond). 1997 Jan;92(1):69-73.

PMID:
9038594
35.

Effect of omeprazole therapy on the survival of Helicobacter pylori, urease activity, and antral gastric histology in patients with duodenal ulcer.

Nakshabendi IM, Zhang QB, Mokhashi M, Gemmell CG, Lee FD, Russell RI.

Helicobacter. 1996 Sep;1(3):155-8.

PMID:
9398897
36.
37.

Studies into the role of the SEF14 fimbrial antigen in the pathogenesis of Salmonella enteritidis.

Thorns CJ, Turcotte C, Gemmell CG, Woodward MJ.

Microb Pathog. 1996 Apr;20(4):235-46.

PMID:
8737493
38.
39.

Antibiotics and the host-parasite relationship (a short review).

Gemmell CG.

Acta Microbiol Immunol Hung. 1996;43(2-3):107-14. Review.

PMID:
8876726
40.

Respiratory burst of human polymorphonuclear leukocytes in response to the galactoside-specific mistletoe lectin.

Braun JM, Gemmell CG, Beuth J, Ko HL, Pulverer G.

Zentralbl Bakteriol. 1995 Nov;283(1):90-4.

PMID:
9810649
41.

Staphylococcal scalded skin syndrome.

Gemmell CG.

J Med Microbiol. 1995 Nov;43(5):318-27. Review.

PMID:
7562995
42.

Neutrophil bactericidal function in diabetes mellitus: evidence for association with blood glucose control.

Gallacher SJ, Thomson G, Fraser WD, Fisher BM, Gemmell CG, MacCuish AC.

Diabet Med. 1995 Oct;12(10):916-20.

PMID:
8846684
43.

Antibiotics and the expression of staphylococcal virulence.

Gemmell CG.

J Antimicrob Chemother. 1995 Aug;36(2):283-91. Review.

PMID:
8522458
44.

Value of oral antibiotic prophylaxis in colorectal surgery.

McArdle CS, Morran CG, Pettit L, Gemmell CG, Sleigh JD, Tillotson GS.

Br J Surg. 1995 Aug;82(8):1046-8.

PMID:
7648148
45.

Oral ciprofloxacin as prophylaxis in gastroduodenal surgery.

McArdle CS, Morran CG, Anderson JR, Pettit L, Gemmell CG, Sleigh JD, Tillotson GS.

J Hosp Infect. 1995 Jul;30(3):211-6.

PMID:
8522777
46.

Post-antibiotic effect of azithromycin and erythromycin on streptococcal susceptibility to phagocytosis.

Ramadan MA, Tawfik AF, Shibl AM, Gemmell CG.

J Med Microbiol. 1995 May;42(5):362-6.

PMID:
7752216
47.
48.

A comparison of different methods of assessing free radical activity in type 2 diabetes and peripheral vascular disease.

MacRury SM, Gordon D, Wilson R, Bradley H, Gemmell CG, Paterson JR, Rumley AG, MacCuish AC.

Diabet Med. 1993 May;10(4):331-5.

PMID:
8508615
49.

Serological diagnosis of Helicobacter pylori--evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs.

Taha AS, Reid J, Boothmann P, Gemmell CG, Lee FD, Sturrock RD, Russell RI.

Gut. 1993 Apr;34(4):461-5.

50.

Opsonic requirements of Helicobacter pylori.

McKinlay AW, Young A, Russell RI, Gemmell CG.

J Med Microbiol. 1993 Mar;38(3):209-15.

PMID:
8455190

Supplemental Content

Loading ...
Support Center